您的位置: 首页 > 农业专利 > 详情页

ANTI-CD19 ANTIBODIES WITH REDUCED IMMUNOGENICITY
专利权人:
MERCK PATENT GMBH
发明人:
MICHAEL SUPER,JONATHAN H. DAVIS,PASCAL ANDRE STEIN
申请号:
PT10008056
公开号:
PT2270050E
申请日:
2006.12.21
申请国别(地区):
PT
年份:
2013
代理人:
摘要:
Pharmaceutical compositions comprising specific anti-CD19 B4 antibodies with modified variable regions in combination with chemotherapeutic agents are disclosed. The modified anti-CD19 variable region polypeptides have alterations to one or more framework regions or complementarity determining regions of the heavy chain variable region or light chain variable region, thereby to reduce a T-cell response. Moreover the specific anti-CD19 antibodies are expressed in good yields in YB2/0 cells and elicit improved ADCC.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充